These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 29717665)

  • 1. Mannosylated Constructs as a Platform for Cell-Specific Delivery of Bioactive Agents.
    Tiwari S
    Crit Rev Ther Drug Carrier Syst; 2018; 35(2):157-194. PubMed ID: 29717665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mannose Ligands for Mannose Receptor Targeting.
    Paurević M; Šrajer Gajdošik M; Ribić R
    Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mannose-Functionalized Nanoscaffolds for Targeted Delivery in Biomedical Applications.
    Hu J; Wei P; Seeberger PH; Yin J
    Chem Asian J; 2018 Nov; 13(22):3448-3459. PubMed ID: 30251341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of Mannosylated Lipopeptides with Receptor Targeting Properties.
    Sedaghat B; Stephenson RJ; Giddam AK; Eskandari S; Apte SH; Pattinson DJ; Doolan DL; Toth I
    Bioconjug Chem; 2016 Mar; 27(3):533-48. PubMed ID: 26735314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Grafting of synthetic mannose receptor-ligands onto onion vectors for human dendritic cells targeting.
    Chenevier P; Grandjean C; Loing E; Malingue F; Angyalosi G; Gras-Masse H; Roux D; Melnyk O; Bourel-Bonnet L
    Chem Commun (Camb); 2002 Oct; (20):2446-7. PubMed ID: 12430483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mannose-targeted systems for the delivery of therapeutics.
    Irache JM; Salman HH; Gamazo C; Espuelas S
    Expert Opin Drug Deliv; 2008 Jun; 5(6):703-24. PubMed ID: 18532925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Synthetic MUC1 Anticancer Vaccine Containing Mannose Ligands for Targeting Macrophages and Dendritic Cells.
    Glaffig M; Stergiou N; Hartmann S; Schmitt E; Kunz H
    ChemMedChem; 2018 Jan; 13(1):25-29. PubMed ID: 29193802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficient targeting to alveolar macrophages by intratracheal administration of mannosylated liposomes in rats.
    Wijagkanalan W; Kawakami S; Takenaga M; Igarashi R; Yamashita F; Hashida M
    J Control Release; 2008 Jan; 125(2):121-30. PubMed ID: 18037185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation and evaluation of mannose receptor mediated macrophage targeting delivery system.
    Zhu L; Chen L; Cao QR; Chen D; Cui J
    J Control Release; 2011 Nov; 152 Suppl 1():e190-1. PubMed ID: 22195844
    [No Abstract]   [Full Text] [Related]  

  • 10. Mannose-functionalized "pathogen-like" polyanhydride nanoparticles target C-type lectin receptors on dendritic cells.
    Carrillo-Conde B; Song EH; Chavez-Santoscoy A; Phanse Y; Ramer-Tait AE; Pohl NL; Wannemuehler MJ; Bellaire BH; Narasimhan B
    Mol Pharm; 2011 Oct; 8(5):1877-86. PubMed ID: 21882825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The potential of mannosylated chitosan microspheres to target macrophage mannose receptors in an adjuvant-delivery system for intranasal immunization.
    Jiang HL; Kang ML; Quan JS; Kang SG; Akaike T; Yoo HS; Cho CS
    Biomaterials; 2008 Apr; 29(12):1931-9. PubMed ID: 18221992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetically engineered mannosylated-human serum albumin as a versatile carrier for liver-selective therapeutics.
    Hirata K; Maruyama T; Watanabe H; Maeda H; Nakajou K; Iwao Y; Ishima Y; Katsumi H; Hashida M; Otagiri M
    J Control Release; 2010 Jul; 145(1):9-16. PubMed ID: 20304018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mannose-targeted mesoporous silica nanoparticles for photodynamic therapy.
    Brevet D; Gary-Bobo M; Raehm L; Richeter S; Hocine O; Amro K; Loock B; Couleaud P; Frochot C; Morère A; Maillard P; Garcia M; Durand JO
    Chem Commun (Camb); 2009 Mar; (12):1475-7. PubMed ID: 19277361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting the mannose receptor with mannosylated subunit vaccines.
    Sedaghat B; Stephenson R; Toth I
    Curr Med Chem; 2014; 21(30):3405-18. PubMed ID: 25174924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design of a nanostructured lipid carrier intended to improve the treatment of tuberculosis.
    Pinheiro M; Ribeiro R; Vieira A; Andrade F; Reis S
    Drug Des Devel Ther; 2016; 10():2467-75. PubMed ID: 27536067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mannosylated liposomes improve therapeutic effects of paclitaxel in colon cancer models.
    Xiong M; Lei Q; You X; Gao T; Song X; Xia Y; Ye T; Zhang L; Wang N; Yu L
    J Microencapsul; 2017 Sep; 34(6):513-521. PubMed ID: 28705043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic evaluation of mannosylated bovine serum albumin as a liver cell-specific carrier: quantitative comparison with other hepatotropic ligands.
    Ogawara K; Hasegawa S; Nishikawa M; Takakura Y; Hashida M
    J Drug Target; 1999; 6(5):349-60. PubMed ID: 10342383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pichia pastoris-produced mucin-type fusion proteins with multivalent O-glycan substitution as targeting molecules for mannose-specific receptors of the immune system.
    Gustafsson A; Sjöblom M; Strindelius L; Johansson T; Fleckenstein T; Chatzissavidou N; Lindberg L; Angström J; Rova U; Holgersson J
    Glycobiology; 2011 Aug; 21(8):1071-86. PubMed ID: 21474492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycosylation influences the ligand binding activities of mannose receptor.
    Su YR; Tsang C; Bakker T; Harris J; Gordon S; Dwek RA; Martinez-Pomares L; Rudd PM
    Adv Exp Med Biol; 2005; 564():25-6. PubMed ID: 16400804
    [No Abstract]   [Full Text] [Related]  

  • 20. Synthesis and characterization of mannosylated oligoribonucleotides.
    Zhao Y; Tram K; Yan H
    Carbohydr Res; 2009 Nov; 344(16):2137-43. PubMed ID: 19765694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.